Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. TSUI (Leuven, Belgium), S. Ronsmans (Centre , Belgium), L. De Sadeleer (Centre , Belgium), P. Hoet (Centre , Belgium), J. Vanoirbeek (Centre , Belgium), B. Nemery (Centre , Belgium). Low-molecular weight agents inducing airway sensitization via skin exposure: a systematic review of experimental models. 5240

Member's Comments

No comment yet.

Related content which might interest you: Comparative airway response to high- versus low-molecular weight agents in occupational asthma Source: Eur Respir J 2009; 33: 734-739 Year: 2009 Predictors of patterns of response following specific inhalation challenge testing with low molecular weight agents. Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Comparison between airway response to high versus low molecular weight agents in occupational asthma Source: Annual Congress 2010 - Occupational asthma Year: 2010 New-onset work-related airway symptoms in workers exposed to high molecular weight (HMW) agents are predicted by clinical markers of airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 509s Year: 2001 Repeated exposure to organic material alters inflammatory and physiological airway responses Source: Eur Respir J 2009; 34: 80-88 Year: 2009 Paracetamol use and asthma: an overview of evidence implicating adult exposure Source: Annual Congress 2012 - Paracetamol and asthma: a causal link? Year: 2012 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006 Usefulness of physiological tests of small airways function in diagnosing asthma: a systematic review Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Is there persistent airway inflammation years after removal from exposure to an agent causing occupational asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 509s Year: 2001 Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015 Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009